We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

14 hedge funds and large institutions have $1.72M invested in AIM ImmunoTech in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 15 → 14 (-1)

11% less capital invested

Capital invested by funds: $1.92M → $1.72M (-$207K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$19.7K
2
VKH
Virtu KCG Holdings
New York
-$13.1K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$12K
4
Renaissance Technologies
Renaissance Technologies
New York
-$6.56K
5
UBS Group
UBS Group
Switzerland
-$6.56K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$663K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$624K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$209K -$6.56K -1 -3%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$103K – – –
Northern Trust
5
Northern Trust
Illinois
$24K – – –
OAM
6
Occidental Asset Management
California
$22K – – –
GC
7
Guggenheim Capital
Illinois
$10K – – –
State Street
8
State Street
Massachusetts
$9K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$8K – – –
BA
10
BlackRock Advisors
Delaware
$8K – – –
BFA
11
BlackRock Fund Advisors
California
$7K – – –
Citadel Advisors
12
Citadel Advisors
Florida
$5K -$19.7K -3 -75%
UBS Group
13
UBS Group
Switzerland
$5K -$6.56K -1 -50%
VKH
14
Virtu KCG Holdings
New York
$3K -$13.1K -2 -67%
Goldman Sachs
15
Goldman Sachs
New York
$3K – – –
TCM
16
Traynor Capital Management
Pennsylvania
$3K – – –
TSS
17
Two Sigma Securities
New York
$3K – – –
EWA
18
Exencial Wealth Advisors
Oklahoma
$2K – – –
Millennium Management
19
Millennium Management
New York
$2K – – –
DC
20
Davenport & Co
Virginia
$1.15K – – –
CHC
21
City Holding Co
West Virginia
$1K – – –
ICAS
22
Investors Capital Advisory Services
Massachusetts
$1K – – –
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
– -$12K -2 Closed
BTS
24
BB&T Securities
Virginia
– -$1K – –

AIM Hedge Fund Activity: Q2 2016 in Review

14 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2016, worth a combined $1.72M — down 11% from $1.92M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of AIM and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.

The largest seller was Citadel Advisors, cutting an estimated $19.7K.

  • 14 institutional investors held AIM ImmunoTech (AIM) as of Q2 2016, down from 15 in Q1 2016.
  • Funds reported $1.72M of AIM ImmunoTech stock for Q2 2016, down 11% quarter-over-quarter.
  • 0 funds opened new AIM ImmunoTech positions in Q2 2016 and 1 closed out, a net change of -1 holder.
  • The largest AIM ImmunoTech seller in Q2 2016 was Citadel Advisors, an estimated $19.7K sold.

Based on aggregated 13F filings for Q2 2016.